Tenaya Therapeutics (TNYA) Other Non-Current Assets (2020 - 2026)

Tenaya Therapeutics has reported Other Non-Current Assets for 7 years, with the latest figure at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 21.36% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 21.36% YoY), and the FY2025 full-year result was $4.2 million, down 11.85% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3.8 million, down from $4.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $5.7 million in Q3 2023, with the low at $399000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $4.5 million, with a median of $4.8 million recorded in 2022.
• Year-over-year, Other Non-Current Assets fell 27.06% in 2022 and jumped 1060.4% in 2023.
• Tracing TNYA's Other Non-Current Assets over 5 years: stood at $4.8 million in 2022, then grew by 18.44% to $5.7 million in 2023, then decreased by 15.15% to $4.8 million in 2024, then retreated by 11.85% to $4.2 million in 2025, then slipped by 10.86% to $3.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.8 million (Q1 2026), $4.2 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.

Peer Comparison